Literature DB >> 17200132

Is supine rest necessary before blood sampling for plasma metanephrines?

Jacques W M Lenders1, Jacques J Willemsen, Graeme Eisenhofer, H Alec Ross, Karel Pacak, Henri J L M Timmers, C G J Fred Sweep.   

Abstract

BACKGROUND: The impact of blood sampling in sitting vs supine positions on measurements of plasma metanephrines for diagnosis of pheochromocytoma is unknown.
METHODS: We compared plasma concentrations of free metanephrines in samples from patients with primary hypertension obtained after supine rest with those obtained in the sitting position without preceding rest. We also assessed the effects on diagnostic test performance retrospectively in patients with and without pheochromocytoma, and we calculated cost-effectiveness for pheochromocytoma testing.
RESULTS: Upper reference limits of plasma free metanephrines were higher in samples obtained from seated patients without preceding rest than from supine patients with preceding rest. Application of these higher upper reference limits to samples from supine patients with pheochromocytoma decreased the diagnostic sensitivity from 99% to 96%. In patients without pheochromocytoma, adjusting the plasma concentration for the effects of sitting while preserving the 99% sensitivity by use of the supine upper reference limits increased the number of false-positive test results from 9% to 25%.
CONCLUSIONS: To preserve high diagnostic sensitivity we recommend the use of upper reference limits determined from blood samples collected in the supine position. Under these conditions, negative test results for blood samples obtained with patients sitting are as effective for ruling out pheochromocytoma as negative results from samples obtained after supine rest. Repeat testing with samples obtained in the supine position offers a cost-effective approach for dealing with the increased numbers of false-positive results expected after initial sampling in the sitting position.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200132     DOI: 10.1373/clinchem.2006.076489

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

1.  Mass spectrometric quantification of salivary metanephrines-A study in healthy subjects.

Authors:  Thamara E Osinga; Anouk N A van der Horst-Schrivers; Martijn van Faassen; Michiel N Kerstens; Robin P F Dullaart; Karel Pacak; Thera P Links; Ido P Kema
Journal:  Clin Biochem       Date:  2016-02-10       Impact factor: 3.281

Review 2.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 3.  From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.

Authors:  Hiren V Patel; Arnav Srivastava; Murray D Becker; Toni Beninato; Amanda M Laird; Eric A Singer
Journal:  Curr Urol Rep       Date:  2021-01-06       Impact factor: 3.092

Review 4.  Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.

Authors:  P Björklund; K Pacak; J Crona
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 5.  Metastatic paraganglioma.

Authors:  Stephanie M J Fliedner; Hendrik Lehnert; Karel Pacak
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

Review 6.  Update on pediatric pheochromocytoma.

Authors:  Bas Havekes; Johannes A Romijn; Graeme Eisenhofer; Karen Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

7.  Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma.

Authors:  Graeme Eisenhofer; Peter Lattke; Maria Herberg; Gabriele Siegert; Nan Qin; Roland Därr; Jana Hoyer; Arno Villringer; Aleksander Prejbisz; Andrzej Januszewicz; Alan Remaley; Victoria Martucci; Karel Pacak; H Alec Ross; Fred C G J Sweep; Jacques W M Lenders
Journal:  Ann Clin Biochem       Date:  2012-10-12       Impact factor: 2.057

Review 8.  Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.

Authors:  G Eisenhofer; G Siegert; J Kotzerke; S R Bornstein; K Pacak
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

9.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

10.  Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma.

Authors:  Alicia Algeciras-Schimnich; Carol M Preissner; William F Young; Ravinder J Singh; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.